首页 > 市场调查报告书 > 製药

非专利药

市场调查报告书

商品编码

1705738

非专利无菌注射剂市场（依药品类型、治疗用途、通路及地区划分）

Generic Sterile Injectables Market, by Drug Type, by Therapeutic Application, by Distribution Channel and by Region

出版日期: 2025年03月03日 | 出版商:

Coherent Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球非专利无菌注射剂市场规模估计为 464.3 亿美元，预计到 2032 年将达到 933.9 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 10.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	464.3亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	10.50%	2032年价值预测	933.9亿美元

数字。 2025 年各地区非专利无菌注射剂市场占有率（%）

非专利无菌注射是美国FDA核准的生技药品，用于治疗医疗保健产业广泛领域的许多疾病和病症。非专利无菌注射剂比这些药物的品牌版本便宜得多，但效果一样好。因此，这些注射剂一直需求量很大，并被世界各地的大多数医院和诊所使用。然而，由于 FDA 对这些注射剂生产的严格规定，满足对这些注射剂的严格需求一直是全球非专利无菌注射剂市场的主要参与者面临的挑战。

随着无菌注射剂越来越多地应用于各种疾病和医疗状况，非专利无菌注射剂市场预计将在可预见的未来获得稳定的发展动力。製造商正致力于增加非专利无菌注射剂的产量，以满足日益增长的需求，同时又不影响注射剂的品质。

市场动态

市场参与者正致力于推出新的非专利无菌注射剂产品，预计这将在预测期内促进全球非专利无菌注射剂的成长。例如，2017 年 6 月，百特国际公司宣布美国 FDA 核准并推出即用型盐酸克林霉素注射液，有三种商业性核准剂型：300 mg/50 美国、600 mg/50 mL 和 900 mg/50 mL。克林霉素是一种抗生素，当青霉素不适合患者时，广泛用于治疗敏感链球菌引起的严重感染疾病。

主要企业正专注于伙伴关係等无机活动，预计这将在预测期内促进全球非专利无菌注射剂市场的成长。例如，2017年，诺华公司的非专利部门山德士扩建了其在斯洛维尼亚的抗生素工厂，投资超过3,354万美元用于开发和现代化该工厂。第一条生产线计划于 2020 年投入使用，新生产线将分阶段投入使用，直至 2024 年。

该公司专注于采用包括收购在内的无机成长策略，以扩大其全球影响力并改善其国际商机。例如，2016年8月，Teva Pharmaceutical Industries Inc.完成对Allergan学名药业务的收购。艾尔建公司 (Allergan Plc) 是一家总部位于爱尔兰的美国製药公司。

本研究的主要特点

本报告对全球非专利无菌注射剂市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模，以 2024 年为基准年。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、区域前景以及主要企业采用的竞争策略的重要见解。
全球非专利无菌注射剂市场的主要企业已根据公司概况、财务绩效、产品系列、地理位置、分销策略、关键发展和策略以及未来计划等参数进行了分析。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、技术改进、市场扩张和行销策略做出明智的决策。
全球非专利无菌注射剂市场报告针对该行业的各个相关人员，包括投资者、供应商、製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球非专利无菌注射剂市场的各种策略矩阵来简化决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 46.43 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.50%	2032 Value Projection:	USD 93.39 Bn

The generic sterile injectable are U.S. FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.

The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.

Market Dynamics

Market players are engaged in launching new products for generic sterile injectables, this is expected to increase the growth of the global generic sterile injectables, over the forecast period. For instance, in June 2017, Baxter International Inc. announced the U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline in three commonly prescribed formulations (300mg/50mL, 600mg/50mL, and 900mg/50mL). Clindamycin is a widely prescribed antibiotic for serious infections which is caused by susceptible anaerobic bacteria and strains of streptococci, pneumococci and staphylococci, when penicillin is inappropriate for a patient.

Key players are focusing on inorganic activities such as partnerships, this is expected to increase the growth of the global generic sterile injectables market, over the forecast period. For instance, in 2017, Novartis' generic arm Sandoz expanded its antibiotic facility in Slovenia, with an investment of over US$ 33.54 million aimed at the development and modernization of facilities. The first production lines started in 2020, after which new lines will be gradually phased in by 2024.

The company is focused on adopting inorganic growth strategies such as acquisitions to expand its global presence and improve international commercial opportunities. For instance, in August 2016, Teva Pharmaceutical Industries Ltd. completed the acquisition of Allergan's generics business. Allergan plc.is an American, Irish-domiciled pharmaceutical company.

Key features of the study:

This report provides an in-depth analysis of the global generic sterile injectables market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global generic sterile injectables market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Baxter International Inc., AstraZeneca plc, Merck & Co., Inc., Pfizer Inc., Fresenius Kabi, Novartis International AG, Teva Pharmaceuticals, Hikma Pharmaceuticals, Dr. Reddy's Laboratory, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global generic sterile injectables market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global generic sterile injectables market

Detailed Segmentation:

Global Generic Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Antibiotics
- Others
Global Generic Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Metabolic Diseases
- Cardiovascular Diseases
- Central Nervous System Disease
- Infectious Disorders
- Musculoskeletal Disorders
- Others
Global Generic Sterile Injectables Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Generic Sterile Injectables Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Baxter International Inc.
- AstraZeneca plc
- Merck & Co., Inc.
- Pfizer Inc.
- Fresenius Kabi
- Novartis International AG
- Teva Pharmaceuticals
- Hikma Pharmaceuticals
- Reddy's Laboratory
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Therapeutic Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. Global Generic Sterile Injectables Market - Impact of Coronavirus (Covid-19) Pandemic

Impact on Supply Chain
Impact on Research and Development
Government Initiatives

5. Global Generic Sterile Injectables Market, By Drug Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Cytokines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Peptide Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

6. Global Generic Sterile Injectables Market, By Therapeutic Application, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Metabolic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Central Nervous System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

7. Global Generic Sterile Injectables Market, By Distribution Channel, 2020 - 2032 (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

8. Global Generic Sterile Injectables Market, By Region, 2020 - 2032 (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020 - 2032
- Regional Trends
North America
- Market Size and Forecast, By Drug Type, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032 (US$ Bn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Drug Type, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032 (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032 (US$ Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032 (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032 (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032 (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032 (US$ Bn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profiles
- Baxter International Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- AstraZeneca plc
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Merck & Co., Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Fresenius Kabi
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Novartis International AG
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Teva Pharmaceuticals
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Hikma Pharmaceuticals
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Reddy's Laboratory
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Mylan N.V.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

非专利无菌注射剂市场（依药品类型、治疗用途、通路及地区划分）